Global clinical trials of an experimental vaccine developed with the University of Oxford has been halted, British drugmaker AstraZeneca Plc said Tuesday, citing "a potentially unexplained illness" in one of its volunteer participants.A spokesperson for the Japanese arm of AstraZeneca said the pause would include Japan. The firm said last week that clinical trials of the vaccine candidate in the country have begun.The company said its "standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee.""This is a routine ac…READ FULL ARTICLE
